Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Mood disorders are one of the most common causes of disability and impairment around the world and patients with mood disorders, including depression and bipolar disorder, make up the single largest group of patients seen in the Psychiatry Adult Outpatient Program at the Johns Hopkins Bayview Medical Center. So we have assembled a comprehensive team with specific expertise and experience to provide multidisciplinary evaluation and ongoing outpatient treatment for individuals with mood disorders.
Our unique, multidisciplinary treatment team includes experienced and licensed mental health care professionals, physicians, psychotherapists, social workers and a research coordinator.
- Individual psychotherapy
- Group psychotherapy
- Medication management
- Family therapy
- Research opportunities
Patients at the Mood Disorders Clinic see both a psychiatrist and a psychotherapist. The combination of psychotherapy and medications has been established to be the most effective treatment for mood disorders, and best supports lasting recovery and stability. This collaborative model provides an advantage to patients allowing for the most effective treatment planning. The frequency of appointment with a therapist is variable depending upon need. Medication management appointments with a psychiatrist are variable as well depending upon the course of the illness and side-effect but they occur at least every 90 days. Therapy frequency varies as needed, and medication management visits occur at least every 90 days. Treatment plans are developed collaboratively by patients and the treatment team. Progress toward goals is assessed regularly in treatment and objectives are updated as needed. For those patients interested in volunteering for a Hopkins research project, a research coordinator in the clinic can facilitate their participation.
We accept Medical Assistance, Medicare, and some private (commercial) insurance. Insurance coverage will be verified prior to your first appointment.
To schedule an appointment, please call 410-550-0104 to speak with the intake specialist, Suzanne Mannion.
Director: Francis M. Mondimore, M.D.
Mood Disorders Clinic at Bayview
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, D-2-East
Baltimore, MD 21224
Phone 410-550-0104 / Fax 410-550-1748
E-mail – firstname.lastname@example.org
Monday – Friday, 8:30-6:00 | DIRECTIONS
Research Participation Opportunities
> Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
We are looking for adults ages 18 and older who have bipolar disorder and are not pregnant. Our purpose is to stabilize participants with bipolar disorder on lithium alone in order to learn which genes are associated with a good response to medication. The study lasts up to 2.5 years, and involves clinician assessments, questionnaires, routine lab work, and taking a blood sample for DNA. You will be paid for participating in this research. You will receive ongoing care during the course of the study from our study psychiatrist, Dr. Francis Mondimore, at the Johns Hopkins Bayview Mood Disorders Clinic. Or, you can continue to receive your clinical care from your current psychiatrist in close consultation with Dr. Mondimore while you participate in the study. For more information, please call 410-550-1652 or email email@example.com. Principal Investigator: Peter Zandi, PhD, MPH, MHS (IRB Protocol NA_00043300). Brochure.
> National Network of Depression Centers Clinical Care Registry (NNDC CCR)
The National Network of Depression Centers (NNDC) is leading an effort to establish a clinical registry that will gather information from people across the nation. As a person touched by a mood disorder, we invite you to share your experience, so that we can better understand mood disorders and their treatment. For more information about this research study, please call 410-550-1652 or 410-614-1017. Principal Investigator: Peter Zandi, PhD, MPH, MHS (IRB Protocol NA_00040237). Information Sheet